Content thumbnail ESG Report | CVS Health
AI Content Chat (Beta) logo

2021 ESG Report Healthy People Making Healthier Happen for Millions The future of kidney care progression of the disease. We do 2021, CVS Health announced a Treatment for chronic kidney this by reaching patients where they partnership between Coram®, our in- disease (CKD) and end stage renal are, promoting in-home dialysis home infusion business, and Cancer disease (ESRD) can be challenging and partnering with CVS Health’s Treatment Centers of America and costly for patients and their community-based resources, such (CTCA) to deliver chemotherapy families, especially in Black and as HealthHUBs. treatment to patients in the safety Hispanic communities — as well and comfort of home. Visits from as for the health care system. In-home chemotherapy a Coram nurse to administer CVS Kidney Care®, a CVS Health For immunocompromised cancer the therapy can be paired with company, embraces a new patients in chemotherapy, the telehealth and digital check-ins approach focused on early COVID-19 pandemic presented with CTCA care team members, identification of kidney disease, a heightened risk of exposure to allowing patients with a range of targeted patient engagement and the virus when seeking inpatient cancers to safely continue their ongoing education to help slow the or in-office treatment. In January critical cancer care. 18

ESG Report | CVS Health - Page 18 ESG Report | CVS Health Page 17 Page 19